- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 457/06 - Lysergic acid amides
Patent holdings for IPC class C07D 457/06
Total number of patents in this class: 77
10-year publication summary
|
2
|
4
|
4
|
0
|
6
|
14
|
13
|
14
|
10
|
4
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| VeroScience LLC | 69 |
7 |
| Ceruvia Lifesciences LLC | 13 |
7 |
| Gilgamesh Pharmaceuticals, Inc. | 62 |
6 |
| BetterLife Pharma Inc. | 11 |
6 |
| Florida State University Research Foundation, Inc. | 839 |
5 |
| Terran Biosciences, Inc. | 107 |
5 |
| Lek Pharmaceuticals d.d. | 181 |
3 |
| Synex Holdings BV | 3 |
3 |
| Regents of the University of Minnesota | 2791 |
2 |
| Theaprin Pharmaceuticals Inc. | 32 |
2 |
| Xoc Pharmaceuticals, Inc. | 11 |
2 |
| Transcend Biodynamics LLC | 2 |
2 |
| GATC Health Corp | 29 |
2 |
| Pike Therapeutics Inc. | 41 |
2 |
| Mindset Pharma Inc. | 66 |
2 |
| CY Biopharma AG | 7 |
2 |
| 2A Biosciences, Inc. | 10 |
2 |
| Seaport Therapeutics, Inc. | 28 |
2 |
| MAP Pharmaceuticals, Inc. | 50 |
1 |
| Pharmacia Italia S.p.A. | 1 |
1 |
| Other owners | 13 |